SARAH HENRY-WALKER: Open Payments
NPI 1346278447 · ERIE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 23 payments from 6 companies in 2025. Trend: 2023 $295 · 2024 $342 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 12 | $155 |
| ViiV Healthcare Company | 4 | $107 |
| ABBVIE INC. | 2 | $46 |
| Organon LLC | 3 | $44 |
| Merck Sharp & Dohme LLC | 1 | $26 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
Products named: APRETUDE, MAVYRET, NEXPLANON, GARDASIL 9, CAPLYTA.
Industry payments across PA — which companies pay providers there.
